Canada Post Corp Registered Pension Plan Purchases 1,500 Shares of McKesson Corporation $MCK

Canada Post Corp Registered Pension Plan increased its position in McKesson Corporation (NYSE:MCK) by 79.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,395 shares of the company’s stock after acquiring an additional 1,500 shares during the period. Canada Post Corp Registered Pension Plan’s holdings in McKesson were worth $2,586,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of MCK. Concord Asset Management LLC VA grew its stake in shares of McKesson by 6.0% during the 3rd quarter. Concord Asset Management LLC VA now owns 3,782 shares of the company’s stock valued at $2,922,000 after purchasing an additional 213 shares during the period. Wellington Shields Capital Management LLC boosted its holdings in shares of McKesson by 0.4% in the third quarter. Wellington Shields Capital Management LLC now owns 7,671 shares of the company’s stock worth $5,926,000 after buying an additional 30 shares during the last quarter. Greater Midwest Financial Group LLC grew its position in McKesson by 1.1% during the third quarter. Greater Midwest Financial Group LLC now owns 1,504 shares of the company’s stock valued at $1,162,000 after buying an additional 16 shares during the period. Concord Wealth Partners increased its holdings in McKesson by 4.8% during the third quarter. Concord Wealth Partners now owns 3,740 shares of the company’s stock valued at $2,889,000 after buying an additional 171 shares during the last quarter. Finally, Wellington Shields & Co. LLC raised its position in McKesson by 6.4% in the third quarter. Wellington Shields & Co. LLC now owns 2,495 shares of the company’s stock worth $1,927,000 after acquiring an additional 151 shares during the period. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on MCK. Evercore restated an “outperform” rating and issued a $1,000.00 price objective on shares of McKesson in a research note on Thursday, November 6th. Jefferies Financial Group upped their price target on McKesson from $820.00 to $900.00 and gave the stock a “buy” rating in a research report on Monday, October 13th. Wells Fargo & Company raised their price objective on McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research note on Thursday. Weiss Ratings cut McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday. Finally, Barclays started coverage on shares of McKesson in a report on Monday, December 8th. They issued an “overweight” rating and a $960.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, McKesson has an average rating of “Moderate Buy” and a consensus target price of $918.93.

Key Stories Impacting McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Q3 results beat consensus: EPS topped estimates and revenue grew ~11.4% year‑over‑year; management raised FY‑2026 adjusted EPS guidance to $38.80–$39.20, underpinning today’s rally. McKesson Q3 Earnings Call Highlights
• Positive Sentiment: Growth drivers called out on the call: oncology, specialty distribution and technology businesses accelerated, which McKesson cites as the basis for the raised profit outlook. MCK Q3 Earnings & Sales Top Estimates, 2026 View Up
• Positive Sentiment: Strong market reaction: analysts and investors pushed the share price sharply higher on the beat + guidance, citing the bigger‑than‑expected lift to FY26 adjusted EPS. How McKesson Stock Surged 17% In A Day
• Neutral Sentiment: Analyst target changes mixed: some firms raised price targets (e.g., Wells Fargo, Mizuho) but ratings stayed neutral/equal‑weight, leaving upside expectations varied among brokers. Price Target Raised to $925.00 at Wells Fargo & Company
• Neutral Sentiment: Company materials and transcripts are available for detailed review (presentation and full earnings call transcript) — useful for checking segment KPIs, margin drivers and guidance assumptions. Q3 2026 earnings call transcript
• Negative Sentiment: Operational cash flow weakness flagged: some reports note weaker operating cash flow despite profit growth, and balance‑sheet metrics (higher liabilities) warrant watching for sustainability of buybacks/dividends. EPS Beats, Profit Growth but Weak Operating Cash Flow
• Negative Sentiment: Insider selling is noted in recent filings; combined with high share price momentum, this can contribute to near‑term volatility or profit‑taking. Insider Trading and Hedge Fund Activity

McKesson Stock Down 1.0%

NYSE MCK opened at $947.96 on Friday. McKesson Corporation has a twelve month low of $583.55 and a twelve month high of $971.93. The business has a 50-day moving average price of $828.41 and a 200-day moving average price of $780.06. The firm has a market cap of $116.12 billion, a price-to-earnings ratio of 27.26, a price-to-earnings-growth ratio of 1.55 and a beta of 0.40.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the prior year, the company posted $8.03 EPS. The firm’s revenue for the quarter was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Research analysts expect that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Monday, March 2nd. McKesson’s payout ratio is currently 9.43%.

Insider Buying and Selling

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the transaction, the executive vice president owned 2,268 shares of the company’s stock, valued at $1,851,096.24. This represents a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.08% of the stock is currently owned by insiders.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.